Dallas Nephrology Associates Named 2025 Acclaim Award Honoree by the American Medical Group Association
Dallas Nephrology Associates (DNA) is proud to announce its recognition as a 2025 Acclaim Award Honoree by the American Medical Group Association (AMGA). This prestigious award was presented to DNA during AMGA’s Annual Conference at the Gaylord Texan Resort & Convention Center in Grapevine, TX, on March 28, 2025. The recognition marks DNA’s second award by a leading national organization in the last year, highlighting the organization’s work in the field of value-based care as an independent specialist practice.
Dallas Nephrology Associates is Pioneering Value-Based Care, Transforming Kidney Disease Management
Dallas Nephrology Associates (DNA), the largest nephrology practice in Texas, has received national recognition for a revolutionary new practice model that has improved patient care and could save payors millions of dollars. DNA has participated in several projects with Medicare that has already resulted in millions of dollars in savings to the agency. Nephrology is the medical specialty dedicated to the study of the kidneys, encompassing their diagnosis, treatment, and management. For many with chronic kidney disease (CKD), this innovative value-based care model has been life-changing.
